{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:36:43Z","timestamp":1791175003309,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,25]],"date-time":"2008-10-25T00:00:00Z","timestamp":1224892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10585-008-9223-x","type":"journal-article","created":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T10:11:18Z","timestamp":1224843078000},"page":"133-141","source":"Crossref","is-referenced-by-count":27,"title":["A role for leukemia inhibitory factor in melanoma-induced bone metastasis"],"prefix":"10.1007","volume":"26","author":[{"given":"Shigeaki","family":"Maruta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ueyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masazumi","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,25]]},"reference":[{"key":"9223_CR1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655\u20131664. doi: 10.1056\/NEJMra030831","journal-title":"N Engl J Med"},{"key":"9223_CR2","first-page":"4040","volume":"56","author":"H Iguchi","year":"1996","unstructured":"Iguchi H, Tanaka S, Ozawa Y et al (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56:4040\u20134043","journal-title":"Cancer Res"},{"key":"9223_CR3","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1182\/blood.V98.13.3534","volume":"98","author":"PI Croucher","year":"2001","unstructured":"Croucher PI, Shipman CM, Lippitt J et al (2001) Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Blood 98:3534\u20133540. doi: 10.1182\/blood.V98.13.3534","journal-title":"Blood"},{"key":"9223_CR4","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","volume":"100","author":"M Abe","year":"2002","unstructured":"Abe M, Hiura K, Wilde J et al (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 100:2195\u20132202","journal-title":"Blood"},{"key":"9223_CR5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA, Yin JJ, Taylor SD et al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544\u20131549. doi: 10.1172\/JCI118947","journal-title":"J Clin Invest"},{"key":"9223_CR6","first-page":"2665","volume":"24","author":"E Onuma","year":"2004","unstructured":"Onuma E, Sato K, Saito H et al (2004) Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy. Anticancer Res 24:2665\u20132673","journal-title":"Anticancer Res"},{"key":"9223_CR7","first-page":"208","volume-title":"In vitro culture of human cancer cells","author":"M Shimoyama","year":"1975","unstructured":"Shimoyama M (1975) SEKI strain. In: Oboshi S, Sugano H (eds) In vitro culture of human cancer cells. Asakura Shoten, Tokyo, pp 208\u2013215"},{"key":"9223_CR8","first-page":"2912","volume":"41","author":"Y Kondo","year":"1981","unstructured":"Kondo Y, Sato K, Ueyama Y et al (1981) Serum sialyltransferase and liver catalase activity in cachectic nude mice bearing a human malignant melanoma. Cancer Res 41:2912\u20132916","journal-title":"Cancer Res"},{"key":"9223_CR9","first-page":"6656","volume":"51","author":"M Mori","year":"1991","unstructured":"Mori M, Yamaguchi K, Honda S et al (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 51:6656\u20136659","journal-title":"Cancer Res"},{"key":"9223_CR10","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/j.1460-2075.1987.tb02742.x","volume":"6","author":"DP Gearing","year":"1987","unstructured":"Gearing DP, Gough NM, King JA et al (1987) Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 6:3995\u20134002","journal-title":"EMBO J"},{"key":"9223_CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/edrv-12-3-208","volume":"12","author":"R Kurzrock","year":"1991","unstructured":"Kurzrock R, Estrov Z, Wetzler M et al (1991) LIF: not just a leukemia inhibitory factor. Endocr Rev 12:208\u2013217","journal-title":"Endocr Rev"},{"key":"9223_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/1043-4666(94)90045-0","volume":"6","author":"HR Alexander","year":"1994","unstructured":"Alexander HR, Billingsley KG, Block MI et al (1994) D-factor\/leukaemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease. Cytokine 6:589\u2013596. doi: 10.1016\/1043-4666(94)90045-0","journal-title":"Cytokine"},{"key":"9223_CR13","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","volume":"169","author":"P Palmqvist","year":"2002","unstructured":"Palmqvist P, Persson E, Conaway HH et al (2002) IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353\u20133362","journal-title":"J Immunol"},{"key":"9223_CR14","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","volume":"123","author":"N Takahashi","year":"1988","unstructured":"Takahashi N, Akatsu T, Udagawa N et al (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600\u20132602","journal-title":"Endocrinology"},{"key":"9223_CR15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1177\/34.10.3745910","volume":"34","author":"FP Wijngaert van de","year":"1986","unstructured":"van de Wijngaert FP, Burger EH (1986) Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. J Histochem Cytochem 34:1317\u20131323","journal-title":"J Histochem Cytochem"},{"key":"9223_CR16","first-page":"2304","volume":"52","author":"F Arguello","year":"1992","unstructured":"Arguello F, Furlanetto RW, Baggs RB et al (1992) Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl\/Sld and W\/Wv). Cancer Res 52:2304\u20132309","journal-title":"Cancer Res"},{"key":"9223_CR17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/S0046-8177(03)00404-0","volume":"34","author":"Y Oda","year":"2003","unstructured":"Oda Y, Takahira T, Kawaguchi K et al (2003) Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications. Hum Pathol 34:1035\u20131042. doi: 10.1053\/S0046-8177(03)00404-0","journal-title":"Hum Pathol"},{"key":"9223_CR18","first-page":"5571","volume":"62","author":"MS Bendre","year":"2002","unstructured":"Bendre MS, Gaddy-Kurten D, Mon-Foote T et al (2002) Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62:5571\u20135579","journal-title":"Cancer Res"},{"key":"9223_CR19","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","volume":"65","author":"MS Bendre","year":"2005","unstructured":"Bendre MS, Margulies AG, Walser B et al (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001\u201311009. doi: 10.1158\/0008-5472.CAN-05-2630","journal-title":"Cancer Res"},{"key":"9223_CR20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1359\/jbmr.2002.17.5.774","volume":"17","author":"K Ono","year":"2002","unstructured":"Ono K, Akatsu T, Murakami T et al (2002) Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. J Bone Miner Res 17:774\u2013781. doi: 10.1359\/jbmr.2002.17.5.774","journal-title":"J Bone Miner Res"},{"key":"9223_CR21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ijc.2910560617","volume":"56","author":"S Mattei","year":"1994","unstructured":"Mattei S, Colombo MP, Melani C et al (1994) Expression of cytokine\/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853\u2013857. doi: 10.1002\/ijc.2910560617","journal-title":"Int J Cancer"},{"key":"9223_CR22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0959-8049(97)00513-3","volume":"33","author":"OH Sanchez-Sweatman","year":"1997","unstructured":"Sanchez-Sweatman OH, Lee J, Orr FW et al (1997) Direct osteolysis induced by metastatic murine melanoma cells: role of matrix metalloproteinases. Eur J Cancer 33:918\u2013925. doi: 10.1016\/S0959-8049(97)00513-3","journal-title":"Eur J Cancer"},{"key":"9223_CR23","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/0008-5472.CAN-06-1021","volume":"67","author":"M Wysoczynski","year":"2007","unstructured":"Wysoczynski M, Miekus K, Jankowski K et al (2007) Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res 67:2131\u20132140. doi: 10.1158\/0008-5472.CAN-06-1021","journal-title":"Cancer Res"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-008-9223-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-008-9223-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-008-9223-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:44:16Z","timestamp":1589035456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-008-9223-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["9223"],"URL":"https:\/\/doi.org\/10.1007\/s10585-008-9223-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,25]]}}}